Literature DB >> 32620030

Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).

Besa Emini Veseli1, Paola Perrotta1, Pieter Van Wielendaele2, Anne-Marie Lambeir2, Anahita Abdali3, Stefano Bellosta3, Giovanni Monaco4,5, Geert Bultynck4, Wim Martinet1, Guido R Y De Meyer1.   

Abstract

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 (PFKFB3) is a key enzyme of the glycolytic pathway, and it plays an essential role in angiogenesis. 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) is frequently used as a glycolysis inhibitor and is thought to inhibit PFKFB3. However, this latter effect of 3PO has never been investigated in detail and was the aim of the present study. To demonstrate binding of 3PO to PFKFB3, we used isothermal titration calorimetry. However, 3PO did not bind to PFKFB3, even up to 750 µm, in contrast to 3 µm of AZ67, which is a potent and specific PFKFB3 inhibitor. Instead, 3PO accumulated lactic acid inside the cells, leading to a decrease in the intracellular pH and an inhibition of enzymatic reactions of the glycolytic pathway.
© 2020 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  3PO; PFKFB3; glycolysis; intracellular pH; isothermal titration calorimetry

Year:  2020        PMID: 32620030     DOI: 10.1002/1873-3468.13878

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis.

Authors:  Renée J H A Tillie; Jenny De Bruijn; Javier Perales-Patón; Lieve Temmerman; Yanal Ghosheh; Kim Van Kuijk; Marion J Gijbels; Peter Carmeliet; Klaus Ley; Julio Saez-Rodriguez; Judith C Sluimer
Journal:  Front Cell Dev Biol       Date:  2021-08-12

2.  A high-throughput screening campaign against PFKFB3 identified potential inhibitors with novel scaffolds.

Authors:  Jie Li; Yan Zhou; Guy Eelen; Qing-Tong Zhou; Wen-Bo Feng; Viktorija Labroska; Fen-Fen Ma; Hui-Ping Lu; Mieke Dewerchin; Peter Carmeliet; Ming-Wei Wang; De-Hua Yang
Journal:  Acta Pharmacol Sin       Date:  2022-09-16       Impact factor: 7.169

Review 3.  The role of PFKFB3 in maintaining colorectal cancer cell proliferation and stemness.

Authors:  Siyuan Yan; Qianqian Li; Shi Li; Zhiying Ai; Dongdong Yuan
Journal:  Mol Biol Rep       Date:  2022-05-12       Impact factor: 2.742

Review 4.  Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.

Authors:  Brandon C Jones; Paula R Pohlmann; Robert Clarke; Surojeet Sengupta
Journal:  Cancer Metastasis Rev       Date:  2022-04-14       Impact factor: 9.237

Review 5.  Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors.

Authors:  Reinier Alvarez; Debjani Mandal; Prashant Chittiboina
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

Review 6.  Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis.

Authors:  Jianlin Zuo; Jinshuo Tang; Meng Lu; Zhongsheng Zhou; Yang Li; Hao Tian; Enbo Liu; Baoying Gao; Te Liu; Pu Shao
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

7.  Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.

Authors:  V F E D Smolders; C Rodríguez; I Blanco; R Szulcek; Wim Timens; L Piccari; Y Roger; X Hu; Constanza Morén; C Bonjoch; L Sebastián; M Castellà; J Osorio; V I Peinado; Harm Jan Bogaard; P H A Quax; M Cascante; J A Barberà; O Tura-Ceide
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

8.  Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I-Mediated Antiviral Responses in Primary Human Dendritic Cells.

Authors:  Alessandra Zevini; Enrico Palermo; Daniele Di Carlo; Magdalini Alexandridi; Serena Rinaldo; Alessio Paone; Francesca Cutruzzola; Marilena P Etna; Eliana M Coccia; David Olagnier; John Hiscott
Journal:  Front Cell Infect Microbiol       Date:  2022-07-18       Impact factor: 6.073

9.  The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.

Authors:  Besa Emini Veseli; Pieter Van Wielendaele; Mirela Delibegovic; Wim Martinet; Guido R Y De Meyer
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.

Authors:  Ibolya Czegle; Austin L Gray; Minjing Wang; Yan Liu; Jun Wang; Edina A Wappler-Guzzetta
Journal:  Life (Basel)       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.